Crossref
EUROPEAN CLINICAL TRIALS REGULATION 536/2014: CONCERNS AND PERSPECTIVES OF A MEMBER STATE
Annals of Research in Oncology · 2022-09 · 02 (03) · 202
DOI: 10.48286/aro.2022.53 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Research in Oncology, 2022-09. Verfasst von C. Cagnazzo und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cagnazzo, C., Cenna, R., Basiricò, M., & Fagioli, F. (2022). EUROPEAN CLINICAL TRIALS REGULATION 536/2014: CONCERNS AND PERSPECTIVES OF A MEMBER STATE. Annals of Research in Oncology, 02(03), 202. https://doi.org/10.48286/aro.2022.53
Vancouver
Cagnazzo C, Cenna R, Basiricò M, Fagioli F. EUROPEAN CLINICAL TRIALS REGULATION 536/2014: CONCERNS AND PERSPECTIVES OF A MEMBER STATE. Annals of Research in Oncology. 2022;02(03):202. doi:10.48286/aro.2022.53
BibTeX
@article{Cagnazzo2022,
author = {Cagnazzo, C. and Cenna, R. and Basiricò, M. and Fagioli, F.},
title = {EUROPEAN CLINICAL TRIALS REGULATION 536/2014: CONCERNS AND PERSPECTIVES OF A MEMBER STATE},
journal = {Annals of Research in Oncology},
year = {2022},
volume = {02},
number = {03},
pages = {202},
doi = {10.48286/aro.2022.53}
}
EUVIMED